# Drug Data Analysis Summary

Generated on: 2025-07-07 06:11:30

## Key Findings

### Disease Coverage
- **Total Diseases**: 665
- **Diseases with Drugs**: 407 (61.2%)
- **Diseases without Drugs**: 258

### Drug Portfolio
- **Total Unique Drugs**: 885
- **Average Drugs per Disease**: 2.17
- **Approved Drugs**: 466
- **Investigational Drugs**: 0

### Top Diseases by Drug Count
1. **Paroxysmal nocturnal hemoglobinuria** - 50 drugs
2. **Gaucher disease** - 45 drugs
3. **Fabry disease** - 39 drugs
4. **Mucopolysaccharidosis type 3** - 38 drugs
5. **X-linked adrenoleukodystrophy** - 32 drugs
6. **Niemann-Pick disease type C** - 32 drugs
7. **Glycogen storage disease due to acid maltase deficiency** - 29 drugs
8. **Phenylketonuria** - 26 drugs
9. **Mucopolysaccharidosis type 1** - 25 drugs
10. **Mucopolysaccharidosis type 2** - 25 drugs

### Manufacturer Insights
- **Total Manufacturers**: 0- **Top Manufacturer**: No manufacturer data available


### Regional Distribution
- **EU Coverage**: 12.2%
- **US Coverage**: 100.0%

### Data Quality
- **Drugs with Substance ID**: 52.66%
- **Drugs with Regulatory ID**: 100.0%

### Generated Visualizations

## Analysis Notes
- Drug coverage is 61.2% across rare diseases
- Top disease has 50 drugs
- 3 different regulatory status types identified
- Analysis includes 885 total drug records

---
*This report was generated automatically by the Drug Statistics system.*
